EMAIL DETAILS

Appreciate all the hospitality and it was a pleasure meeting all of you. Look forward to the next update.

From: Neil Callahan (Rosemont Seneca) [mailto:ncallahan@rosemontseneca.com]
Sent: Thursday, February 13, 2014 1:43 PM
To: 'Steven Krein'; Thompson, Bruce; Mamaux, Mike; howard@startuphealth.com; unity@startuphealth.com
Cc: 'Hunter Biden'
Subject: Great meeting you

Hey guys,

It was great seeing you all yesterday. Hopefully the LaGuardia hotels are well stocked for today! We easily have gotten 14 inches of snow so far today in New Jersey and will get another 3-5 inches this evening as the rain changes back to snow.

A great dinner - the SUH team is doing different and needed work within the industry. You've made awesome progress.

The concussion detection company that I mentioned last night is called BioDirection - http://www.biodirection.com/about-us/

They are in the middle of fund raise - their main focus right now is to impact ER protocols and to get trail in trauma centers as well as working on their contract manufacturing supply chain. They feel pretty good about the strength of their IP and the potential for market adoption. They also have a dementia and Alzheimer's test in the works - same technology & form factor - pin prick blood sample onto a slide, into a sensor to detect the indicative bio markers.

If you'd like to learn more I can connect you with a board member and/or the CEO. I am under NDA, so I cannot share investor docs at this point.

Safe travels home and I look forward to the continued dialog.

All the best,

Neil


Neil Callahan
Rosemont Seneca Partners
401 Greenwich Street, Suite 300
New York, New York 10013
917-945-9516 (m)
866-749-8879 (f)
www.rosemontsenecatech.com<http://www.rosemontsenecatech.com/>
Confidentiality Warning: This e-mail contains information intended only for the use of the individual or entity named above. If the reader of this e-mail is not the intended recipient or the employee or agent responsible for delivering it to the intended recipient, any dissemination, publication or copying of this e-mail is strictly prohibited. The sender does not accept any responsibility for any loss, disruption or damage to your data or computer system that may occur while using data contained in, or transmitted with, this e-mail.If you have received this e-mail in error, please immediately notify us by return e-mail. Thank you

-----------------------------------------
CONFIDENTIALITY NOTICE: The information in this Email is confidential and may be privileged. This Email is intended solely for the named recipient or recipients. If you are not the intended recipient, any use, disclosure, copying or distribution of this Email is prohibited. If you are not the intended recipient, please inform us by replying with the subject line marked "Wrong Address" and then deleting this Email and any attachments. Stericycle, Inc. uses regularly updated anti-virus software in an attempt to reduce the possibility of transmitting computer viruses. We do not guarantee, however, that any attachments to this Email are virus-free.

Nota de confidencialidad: La información que presenta este correo es confidencial, y puede ser de uso privilegiado. Este correo intenta ser enviado solo al destinatario, o a los destinatarios. Si usted no es el destinatario, no podrá usar, desglosar, copiar, o distribuir la información de este correo ya que está prohibido. Si usted no es el correcto destinatario, por favor infórmenos reenviándonos el mismo con el asunto ¨Dirección Incorrecta¨, y luego borre el correo y los adjuntos. Stericycle, Inc. usa regularmente actualizaciones de software anti-virus para así reducir posibles virus. De todas maneras, no garantizamos que los adjuntos estén libres de virus